Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 06-Mar-23 6:55 PM View:  | Quince Therapeutics, Inc. (QNCX) | 06-Mar-23 | Sale (Planned) | 1,871 | $0.98 | $1,833.58 | (6%) 29.31K to 27.44K | |
| 07-Dec-22 5:37 PM View: | Quince Therapeutics, Inc. (QNCX) | 05-Dec-22 | Payment of Exercise | 1,640 | $0.72 | $1,180.80 | (5%) 30.95K to 29.31K | |
| 08-Sep-22 5:58 PM View: | Quince Therapeutics, Inc. (QNCX) | 06-Sep-22 | Payment of Exercise | 1,520 | $1.64 | $2,492.80 | (5%) 32.47K to 30.95K | |
| 08-Jun-22 4:13 PM View: | Quince Therapeutics, Inc. (QNCX) | 06-Jun-22 | Payment of Exercise | 1,529 | $3.12 | $4,770.48 | (4%) 34.0K to 32.47K | |
| 04-Mar-22 5:58 PM View: | Quince Therapeutics, Inc. (QNCX) | 03-Mar-22 | Grant | 34,000 | -- | -- | 100% 0 to 34.0K |